Top Markets
#1 Useless Coin Useless Coin +39.03%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.96%
#3 0G 0G +36.39%
#4 StonkBroker StonkBroker +35.78%
#5 SAFEcoin SAFEcoin +29.23%
#6 Arbitrum Arbitrum +22.61%
#7 Zora Zora +20.61%
#8 Full Moon Full Moon +18.06%
#9 Notcoin Notcoin +18.04%
#10 Dogs Dogs +17.45%
Coin of the day
Useless Coin Useless Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Classificação em ações #13820
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Preço da ação
$12.63
Valor de mercado
$458.19M
Variação (1 dia)
-3.26%
Variação (1 ano)
-
País
US
Negociar Evommune, Inc. (EVMN)

Categoria

Healthcare
Histórico de preços das ações de Evommune, Inc. (EVMN)
Preço de fecho mais alto: $13.94 em 2026-08-01

Preço de fecho mais baixo: $19.25 em 2025-11-01
Histórico de preços das ações da Evommune, Inc. de 2025 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 9.44%
2025 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.87%
CH